Squarepoint’s Nu Skin NUS Stock Holding History

Squarepoint’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-18,500	Closed	-$359K	–	4418
2023 Q4	$359K	Buy	+18,500	New	+$341K	﹤0.01%	3242

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Squarepoint's NUS Position: Q2 2025 in Review

Squarepoint sold out of Nu Skin (NUS) in Q2 2025, closing a stake of 14,670 shares — an estimated $107K sold.

Squarepoint first reported a position in NUS in Q3 2015 and held it in 31 quarters. The position peaked at $8.55M in Q3 2020. 179 funds tracked by Wall St. Rank hold NUS as of Q2 2025.

Squarepoint reported no remaining Nu Skin position as of Q2 2025 after selling out during the quarter.
Squarepoint sold 14,670 Nu Skin shares in Q2 2025, an estimated $107K.
Squarepoint first reported a position in Nu Skin in Q3 2015 and held it in 31 quarters.
Squarepoint's Nu Skin position peaked at $8.55M in Q3 2020.
179 funds tracked by Wall St. Rank held Nu Skin as of Q2 2025.

Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.